Narrative review explores neuroinflammation's impact on mental disorders in individuals with pulmonary hypertension, suggesting comprehensive treatment approaches.
The article presents a narrative review of the recent scientific literature regarding mental disorders in patients diagnosed with pulmonary hypertension (PH). Psychosomatic disorders were considered, first of all, anxiety, depressive, potentially related to the systemic immune-inflammatory process of the underlying disease. Empirical evidence for the high prevalence of these disorders across various forms of PH is discussed, along with an exploration of the biological mechanisms underlying their onset. The findings underscore the necessity for a comprehensive multimodal approach to both diagnosis and treatment of mental disorders in individuals with PH. This approach should incorporate psychopharmacotherapy and the management of neuroinflammatory processes to enhance overall quality of life.
No takes yet. Share an insight, caveat, or question.
Samushiya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: